Pioglitazone: a review of Japanese clinical studies.

  title={Pioglitazone: a review of Japanese clinical studies.},
  author={Sachiko Baba},
  journal={Current medical research and opinion},
  volume={17 3},
  • Sachiko Baba
  • Published 2001 in Current medical research and opinion
Pioglitazone, a new thiazolidinedione agent,has been shown to increase insulin sensitivity in clinical trials. Pioglitazone HCI was rapidly absorbed within one hour, achieved peak concentrations at 2-3 h, and was eliminated from serum at 24-36 h. Pioglitazone demonstrated dose-dependent pharmacokinetics. Food did not significantly affect the pharmacokinetic… CONTINUE READING